NOTV
Inotiv Inc
NASDAQ: NOTV · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.29
-27.65% today
Updated 2026-06-04
Market cap
$5.79M
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-2.48
Dividend yield
—
52W range
$0 – $3
Volume
1.6M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F2.5
Quality
F2.0
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-1.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$3.25
+1006.95%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -1.05 — distress zone
- Thin margins at -17.10%
- Negative free cash flow $-3.17M
- Revenue declining -5.40% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $547.66M | $572.42M | $490.74M | $513.02M | $507.36M |
| Net income | $-337.26M | $-105.14M | $-108.44M | $-68.63M | $-32.47M |
| EPS | — | — | — | — | $-2.48 |
| Free cash flow | $-41.52M | $380000.00 | $-29.11M | $-27.07M | $-3.17M |
| Profit margin | -61.58% | -18.37% | -22.10% | -13.38% | -17.10% |
Peer comparison
Smart narrative
Inotiv Inc trades at $0.29. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -1.05, it sits in the distress. TTM revenue stands at $507.36M. with profit margins at -17.10%.
Frequently asked questions
What is Inotiv Inc's stock price?
Inotiv Inc (NOTV) trades at $0.29, on a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Inotiv Inc overvalued?
Inotiv Inc carries a Smart Value Score of 31/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Inotiv Inc (NOTV)?
The 12-month analyst consensus target is $3.25, about 1006.9% above the current $0.29. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Inotiv Inc's revenue?
Inotiv Inc's trailing twelve-month revenue is $507.36M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Inotiv Inc's Altman Z-Score is -1.05, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.01x
ROE-74.10%
Beta3.78
50D MA$0.28
200D MA$0.76
Shares out0.03B
Float0.03B
Short ratio—
Avg volume1.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—